CTOs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

Bloomer Trailer Mfg Inc

Bloomer Trailer Mfg Inc is an automotive company based out of P.O. BOX 1191, Salado, Texas, United States.

Dr. Phillips Center for the Performing Arts

The Dr. Phillips Center for the Performing Arts is a leading cultural venue located in downtown Orlando, Florida. It showcases a wide array of performances, including theater productions, concerts, dance, and comedy shows. The center is dedicated to making the arts accessible to everyone, guided by its mission of "Arts For Every Life." Facilities at the center include the Walt Disney Theater for major productions, Steinmetz Hall for orchestral performances, and the Alexis & Jim Pugh Theater for smaller shows. The AdventHealth School of the Arts offers educational programs in music, theater, dance, and visual arts. Additionally, the center hosts community outreach events and provides spaces for private gatherings, making it a vibrant hub for cultural exchange and creativity in the community.

Oden Machinery, Inc.

Oden Machinery, Inc. provides customers worldwide with liquid filling and processing machinery backed by over three decades of industry-leading innovation in design and engineering solutions. Oden is a leading U.S. manufacturer of filling and processing machinery for the liquid products markets and provides complete turnkey liquid packaging lines. Custom designed systems for form/fill/seal, bag-in-box, retort, explosion proof, and other specialized liquid packaging applications are also available. In August 2010, Oden partnered with Green Frontier LLC to help companies optimize their liquid processing operations and reduce their impact on the environment. The Oden Process Equipment Group offers continuous stream digital blending systems, automated batch addition systems, and liquid product transfer systems, all designed to reduce labor costs, enhance product quality, increase production capacity, and decrease generation of waste and scrap. Our customers​ businesses span a broad range of industries, including pharmaceutical, personal care products, food processing, household products, general industrial, automotive products, petroleum products, and the chemical processing industries. If your packaging/processing operations include filling or processing liquid products, we encourage you to visit www.odencorp.com. If you need an off the shelf"​ machine or require highly specialized machinery give us a call, 800-658-3622.

R.H. Sheppard Co. Inc.

With a legacy of achievement and innovation, R.H. Sheppard Cp., Inc. is a global leader in power steering and diesel engine pump technologies for the commercial vehicle industry, with the introduction of the D-Series family of power steering gears and the continued development of the M-Series. Today Sheppard continues to develop and introduce new steering system products, including miter and T-boxes, miter columns, steering columns, and other linkages. Sheppards headquarters campus is in Hanover, Pa., where it conducts engineering, testing, manufacturing, remanufacturing, and distribution. It also operates a machining facility in Wytheville, Va., along with an R&D Center in Shelby Township, Mich.

IMUNON

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.